Clinical trial
Prospective, Multicenter, Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Bleeding Adult Cardiac Surgical Patients
NCT05523297 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multicenter, Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Bleeding Adult Cardiac Surgical Patients
- Lead sponsor
- Octapharma
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2022
- Completion date
- June 27, 2024
- Enrollment
- 420 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
bleeding cardiac surgery patients